Showing 8471-8480 of 18146 results for "".
- GLP-1 Receptor Agonists: Bridging Metabolic Control and Cardiovascular Protectionhttps://reachmd.com/news/glp-1-receptor-agonists-bridging-metabolic-control-and-cardiovascular-protection/2475771/The expanding use of GLP-1 receptor agonists such as Ozempic is challenging the traditional divide between metabolic control and cardiovascular protection, unveiling underrecognized potential for stroke prevention in patients with type 2 diabetes. The utilization of
- Weight Loss and Glucose Management: Transitioning from Old to New Medicationshttps://reachmd.com/news/weight-loss-and-glucose-management-transitioning-from-old-to-new-medications/2474175/Emerging research affirms that next-generation weight loss and glucose management medications are transforming treatment outcomes for patients with type 2 diabetes, offering superior efficacy and potential economic savings. The advent of these c
- Compound from Olives Shows Promise for Treating Obesity and Diabetes, Claims Studyhttps://reachmd.com/news/compound-from-olives-shows-promise-for-treating-obesity-and-diabetes-claims-study/2467587/Chicago: Findings from a new mouse study suggest that elenolic acid, a natural compound found in olives, can lower blood sugar levels and promote weight loss.The research could pave the way to the development of safe and inexpensive natural products for managing
- Study Reveals Avocado May Lower Diabetes Risk in Women, Not Menhttps://reachmd.com/news/study-reveals-avocado-may-lower-diabetes-risk-in-women-not-men/2463092/In a recent cross-sectional study published in the Journal of the Academy of Nutrition and Dietetics, researchers from Mexico investigat
- New Study Focuses on the Placenta for Clues to the Development of Gestational Diabeteshttps://reachmd.com/news/new-study-focuses-on-the-placenta-for-clues-to-the-development-of-gestational-diabetes/2462758/Marie-France Hivert, MD, MMSc BOSTON, MA – A new study led by the Harvard Pilgrim Health Care Institute has identified that a deficit in the placental expression of the gene insulin-like growth factor 1 (IGFBP1) and low IGFBP
- Machine Learning Can Predict Eyes at Risk for Diabetic Retinopathy Progressionhttps://reachmd.com/news/machine-learning-can-predict-eyes-at-risk-for-diabetic-retinopathy-progression/2457233/by Lori Solomon Automated machine learning models may help identify eyes
- Therapeutic Plasma Exchange and Biological Aging: A New Hope in Geriatricshttps://reachmd.com/news/therapeutic-plasma-exchange-and-biological-aging-a-new-hope-in-geriatrics/2474990/Clinicians have long sought interventions capable of reversing biological aging and improving patient resilience, and now a
- Bridging ADHD and Metabolic Disorders: Clinical Implications of Shared Pathwayshttps://reachmd.com/news/bridging-adhd-and-metabolic-disorders-clinical-implications-of-shared-pathways/2474583/Exploring the critical connection between ADHD and metabolic disorders reveals insights into dopamine gene modifications, challenges in glycemic regulation, and the effects of maternal diabetes on children. Insights from Diabetes and Endocrinolo
- Advancing Detection: Maternal A1c as a Diagnostic Tool in Early GDM Identificationhttps://reachmd.com/news/advancing-detection-maternal-a1c-as-a-diagnostic-tool-in-early-gdm-identification/2473840/The pursuit of earlier, more effective screening strategies for gestational diabetes mellitus (GDM) has led to growing interest in a nontraditional yet accessible biomarker: maternal hemoglobin A1c (HbA1c). While traditionally reserved for diabetes monitoring outsi
- Op-Ed: Confessions of a 31 Year-Old Doctor with 1 Million in Debthttps://reachmd.com/news/op-ed-confessions-of-a-31-year-old-doctor-with-1-million-in-debt/2457401/To understand how I accrued $1 million in debt, you must first understand where I come from.